Adalimumab and Crohn's disease; A long-term real world experience

被引:0
|
作者
Iqbal, J. [1 ]
Kemp, K. [1 ]
Hodgins, J. [1 ]
Chan, L. [1 ]
Willert, R. [1 ]
Makin, A. [1 ]
Campbell, S. [1 ]
机构
[1] Manchester Royal Infirm, Dept Gastroenterol, Manchester M13 9WL, Lancs, England
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A88 / A88
页数:1
相关论文
共 50 条
  • [21] Long-term treatment outcome of Castleman's disease: A real-world experience
    Min, Gi-June
    Jeon, Young-Woo
    Kim, Tong Yoon
    Kwag, Dae Hun
    Lee, Jong Hyuk
    Lee, Joon Yeop
    Park, Sung-Soo
    Park, Silvia
    Yoon, Jae-Ho
    Lee, Sung-Eun
    Cho, Byung-Sik
    Eom, Ki-Seong
    Kim, Yoo-Jin
    Lee, Seok
    Kim, Hee-Je
    Min, Chang-Ki
    Lee, Jong Wook
    Cho, Seok-Goo
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [22] Long-Term Outcomes With Adalimumab Therapy in Pediatric Crohn Disease: Associations With Adalimumab Exposure
    Rinawi, Firas
    Popalis, Cynthia
    Tersigni, Claudia
    Frost, Karen
    Muise, Aleixo
    Church, Peter C.
    Walters, Thomas D.
    Ricciuto, Amanda
    Griffiths, Anne M.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2022, 74 (03): : 389 - 395
  • [23] Long-term outcomes of adalimumab in patients with Crohn's disease: Can a doubled dose of adalimumab improve outcomes?
    Kanazawa, J.
    Yokoyama, K.
    Matsumoto, Y.
    Kawagishi, K.
    Mukae, M.
    Kubota, M.
    Kobayashi, K.
    Koizumi, W.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S367 - S368
  • [24] Long-term safety and effectiveness of adalimumab in Japanese patients with Crohn's disease: 3-year results from a real-world study
    Hisamatsu, Tadakazu
    Suzuki, Yasuo
    Kobayashi, Mariko
    Hagiwara, Takashi
    Kawaberi, Takeshi
    Ogata, Haruhiko
    Matsui, Toshiyuki
    Watanabe, Mamoru
    Hibi, Toshifumi
    INTESTINAL RESEARCH, 2021, 19 (04) : 408 - 418
  • [25] Long-term real-world data of ustekinumab in Crohn's disease: the Stockholm ustekinumab study
    Bello, Francesca
    Muhsen, Samer
    Sabhan, Haider
    Borin, Alexandra
    Johansson, Fredrik
    Hoog, Charlotte
    Forsberg, Ole
    Wennerstrom, Christina
    Soderman, Charlotte
    Lordal, Mikael
    Almer, Sven
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2024, 17
  • [26] Long-term safety and efficacy of adalimumab in Japanese patients with moderate to severe Crohn's disease
    Watanabe, Mamoru
    Hibi, Toshifumi
    Mostafa, Nael M.
    Chao, Jingdong
    Arora, Vipin
    Camez, Anne
    Petersson, Joel
    Thakkar, Roopal
    JOURNAL OF CROHNS & COLITIS, 2014, 8 (11): : 1407 - 1416
  • [27] Long-term Effectiveness of Adalimumab in Crohn's Disease: Observational Data from the PYRAMID Registry
    Loftus, Edward
    D'Haen, Geert
    Reinisch, Walter
    Satsangi, Jack
    Panaccione, Remo
    Thakkar, Roopal
    Eichner, Samantha
    Castillo, Majin
    Kan-Dobrosky, Natalia
    Skup, Martha
    Chao, Jingdong
    Mulani, Parvez
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S543 - S544
  • [28] Adalimumab for Luminal and Perianal Crohn's Disease in Real Practice: A Long-Term Multicenter Study of Effectiveness, Safety and Predictors of Response
    Ormaechea, Jose Ignacio Fortea
    Gonzalez-Lama, Yago
    Casis, Begona
    Chaparro, Maria
    Lopez-Serrano, Pilar
    Van Domselaar, Manuel
    Bermejo, Fernando
    Pajares, R.
    Diaz, Angel Ponferrada
    Vera, Isabel
    Martinez, Pilar
    Gisbert, Javier P.
    Perez-Calle, Jose L.
    Lopez-San Roman, Antonio
    Abreu, Luis E.
    Menchen, Luis A.
    Marin-Jimenez, Ignacio
    GASTROENTEROLOGY, 2010, 138 (05) : S697 - S697
  • [29] Long-Term, Real-World Safety of Adalimumab in Rheumatoid Arthritis
    Harrold, Leslie R.
    Griffith, Jenny
    Litman, Heather J.
    Gershenson, Bernice
    Islam, Syecl
    Barr, Christine J.
    Guo, Dianlin
    Zueger, Patrick
    Fay, Jonathan
    Greenberg, Jeffrey
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [30] Real-world long-term effectiveness of ustekinumab in Crohn's disease: results from the ENEIDA registry
    Iborra, Marisa
    Beltran, Belen
    Fernandez-Clotet, Agnes
    Iglesias-Flores, Eva
    Navarro, Pablo
    Rivero, Montserrat
    Gutierrez, Ana
    Sierra-Ausin, Monica
    Mesonero, Francisco
    Ferreiro-Iglesias, Rocio
    Hinojosa, Joaquin
    Calvet, Xavier
    Sicilia, Beatriz
    Gonzalez-Munoza, Carlos
    Antolin, Beatriz
    Gonzalez-Vivo, Maria
    Carbajo, Ana Y.
    Garcia-Lopez, Santiago
    Martin-Cardona, Albert
    Suris, Gerard
    Dolores Martin-Arranz, Maria
    de Francisco, Ruth
    Canete, Fiorella
    Domenech, Eugeni
    Nos, Pilar
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (06) : 1017 - 1030